PubRank

Takashi Noda

Author PubWeight™ 54.82‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genotype-phenotype aspects of type 2 long QT syndrome. J Am Coll Cardiol 2009 2.65
2 Participation of a concealed atriohisian tract in the reentrant circuit of the slow-fast type of atrioventricular nodal reentrant tachycardia. Heart Rhythm 2007 2.03
3 Long QT syndrome with compound mutations is associated with a more severe phenotype: a Japanese multicenter study. Heart Rhythm 2010 2.00
4 Acute and chronic management in patients with Brugada syndrome associated with electrical storm of ventricular fibrillation. Heart Rhythm 2007 1.80
5 Augmented ST-segment elevation during recovery from exercise predicts cardiac events in patients with Brugada syndrome. J Am Coll Cardiol 2010 1.78
6 Effect of sodium-channel blockade on early repolarization in inferior/lateral leads in patients with idiopathic ventricular fibrillation and Brugada syndrome. Heart Rhythm 2011 1.71
7 Catheter ablation of stable and unstable ventricular tachycardias in patients with arrhythmogenic right ventricular dysplasia. J Cardiovasc Electrophysiol 2006 1.64
8 Seasonal and circadian distributions of ventricular fibrillation in patients with Brugada syndrome. Heart Rhythm 2008 1.64
9 Sex hormone and gender difference--role of testosterone on male predominance in Brugada syndrome. J Cardiovasc Electrophysiol 2007 1.63
10 Unique electrophysiologic characteristics of atrioventricular nodal reentrant tachycardia with different ventriculoatrial block patterns: effects of slow pathway ablation and insights into the location of the reentrant circuit. Heart Rhythm 2006 1.59
11 Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome. Heart Rhythm 2004 1.53
12 "Left-variant" atypical atrioventricular nodal reentrant tachycardia: electrophysiological characteristics and effect of slow pathway ablation within coronary sinus. J Cardiovasc Electrophysiol 2006 1.52
13 Age- and genotype-specific triggers for life-threatening arrhythmia in the genotyped long QT syndrome. J Cardiovasc Electrophysiol 2008 1.50
14 Significance of non-type 1 anterior early repolarization in patients with inferolateral early repolarization syndrome. J Am Coll Cardiol 2013 1.47
15 Impact of left ventricular diastolic dysfunction on outcome of catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy. Circ J 2014 1.43
16 Safety and efficacy of implantable cardioverter-defibrillator during pregnancy and after delivery. Circ J 2012 1.43
17 Genotype-specific onset of arrhythmias in congenital long-QT syndrome: possible therapy implications. Circulation 2006 1.42
18 Relationship between oral amiodarone and inappropriate therapy from an implantable cardioverter defibrillator. Circ J 2010 1.40
19 Noninvasive characterization of intra-atrial reentrant tachyarrhythmias after surgical repair of congenital heart diseases. Circ J 2009 1.40
20 Clinical effect of implantable cardioverter defibrillator replacements: when should you resume driving after an implantable cardioverter defibrillator replacement? Circ J 2010 1.39
21 Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome. J Am Coll Cardiol 2003 1.35
22 Long-term prognosis of probands with Brugada-pattern ST-elevation in leads V1-V3. Circ Arrhythm Electrophysiol 2009 1.25
23 Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil. J Am Coll Cardiol 2005 1.11
24 Cellular basis for trigger and maintenance of ventricular fibrillation in the Brugada syndrome model: high-resolution optical mapping study. J Am Coll Cardiol 2006 1.08
25 QRS prolongation is associated with high defibrillation thresholds during cardioverter-defibrillator implantations in patients with hypertrophic cardiomyopathy. Circ J 2009 1.04
26 Mutation site dependent variability of cardiac events in Japanese LQT2 form of congenital long-QT syndrome. Circ J 2008 0.99
27 Initial experience using Excimer laser for the extraction of chronically implanted pacemaker and implantable cardioverter defibrillator leads in Japanese patients. J Cardiol 2013 0.95
28 Stable top-up operation at SPring-8. J Synchrotron Radiat 2006 0.91
29 Efficacy of additional radiofrequency applications for spontaneous dissociated pulmonary vein activity after pulmonary vein isolation in patients with paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 2013 0.90
30 Diagnostic and prognostic value of a type 1 Brugada electrocardiogram at higher (third or second) V1 to V2 recording in men with Brugada syndrome. Am J Cardiol 2006 0.90
31 Electrocardiographic predictors of response to cardiac resynchronization therapy in patients with intraventricular conduction delay. Circ J 2013 0.87
32 Clinical impact of the number of extrastimuli in programmed electrical stimulation in patients with Brugada type 1 electrocardiogram. Heart Rhythm 2011 0.86
33 Prognostic significance of early repolarization in inferolateral leads in Brugada patients with documented ventricular fibrillation: a novel risk factor for Brugada syndrome with ventricular fibrillation. Heart Rhythm 2013 0.85
34 Assessing the applicability of FISH-based prematurely condensed dicentric chromosome assay in triage biodosimetry. Health Phys 2015 0.85
35 Neurally mediated syncope as a cause of syncope in patients with Brugada electrocardiogram. J Cardiovasc Electrophysiol 2009 0.84
36 Seasonality in the strength and spatial scale of processes determining intertidal barnacle population growth. J Anim Ecol 2010 0.83
37 Comparison of long-term follow-up of electrocardiographic features in Brugada syndrome between the SCN5A-positive probands and the SCN5A-negative probands. Am J Cardiol 2007 0.83
38 Clinical and Pathological Impact of Tissue Fibrosis on Lethal Arrhythmic Events in Hypertrophic Cardiomyopathy Patients With Impaired Systolic Function. Circ J 2015 0.81
39 Beneficial effects of cilostazol in a patient with recurrent ventricular fibrillation associated with early repolarization syndrome. Heart Rhythm 2012 0.80
40 Extremely late pacemaker-infective endocarditis due to Stenotrophomonas maltophilia. Cardiology 2007 0.80
41 Cardiac resynchronization therapy to prevent life-threatening arrhythmias in patients with congestive heart failure. J Electrocardiol 2011 0.79
42 Implications of 2:1 atrioventricular block during typical atrioventricular nodal reentrant tachycardia. J Interv Card Electrophysiol 2007 0.78
43 Risk stratification in patients with Brugada syndrome without previous cardiac arrest – prognostic value of combined risk factors. Circ J 2014 0.78
44 Predictors of electrical storm in patients with idiopathic dilated cardiomyopathy--how to stratify the risk of electrical storm. Circ J 2010 0.78
45 Spatial distribution of repolarization and depolarization abnormalities evaluated by body surface potential mapping in patients with Brugada syndrome. Pacing Clin Electrophysiol 2006 0.77
46 Novel algorithm for quantitative assessment of left ventricular dyssynchrony with ECG-gated myocardial perfusion SPECT: useful technique for management of cardiac resynchronization therapy. Ann Nucl Med 2011 0.77
47 The positional relationship between the coronary sinus musculature and the atrioventricular septal junction. Europace 2010 0.76
48 Seasonal and circadian distributions of cardiac events in genotyped patients with congenital long QT syndrome. Circ J 2012 0.76
49 Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) Associated With Ryanodine Receptor (RyR2) Gene Mutations　- Long-Term Prognosis After Initiation of Medical Treatment. Circ J 2016 0.76
50 Site-specific influence of transversal conduction across crista terminalis on recognition of isthmus block. Pacing Clin Electrophysiol 2006 0.75
51 JCS/JHRS 2021 guideline focused update on non-pharmacotherapy of cardiac arrhythmias. J Arrhythm 2022 0.75
52 Comparison of the acute effects of right ventricular apical pacing and biventricular pacing in patients with heart failure. Intern Med 2015 0.75
53 Abrupt heart rate fallings in a patient with biventricular pacing: latent risk for exacerbation of heart failure. Pacing Clin Electrophysiol 2010 0.75
54 Electrophysiologic study-guided amiodarone for sustained ventricular tachyarrhythmias associated with structural heart diseases. Circ J 2008 0.75
55 Endocardial and epicardial substrates of ventricular tachycardia in a patient with Fabry disease. Heart Rhythm 2010 0.75
56 Pronounced Shortening of QT Interval With Mexiletine Infusion Test in Patients With Type 3 Congenital Long QT Syndrome. Circ J 2015 0.75
57 Diagnostic Value of Right Ventricular Dysfunction in Tachycardia-Induced Cardiomyopathy Using Cardiac Magnetic Resonance Imaging. Circ J 2016 0.75
58 Latitudinal gradients in species richness in assemblages of sessile animals in rocky intertidal zone: mechanisms determining scale-dependent variability. J Anim Ecol 2008 0.75
59 Usefulness of scintigraphy to predict electrical storms in severe idiopathic dilated cardiomyopathy. Ann Nucl Med 2013 0.75
60 Mitral isthmus pathology of re-entrant ventricular tachycardia in a patient with idiopathic dilated cardiomyopathy. Europace 2009 0.75
61 Radiofrequency catheter ablation of parasystole originating from the inferior vena cava. Pacing Clin Electrophysiol 2010 0.75
62 Asystole caused by vegetation and abscess of right ventricle attached to a tip of pacemaker lead. Pacing Clin Electrophysiol 2008 0.75
63 Destructive device removal - sparks and deletion of therapy history from an implantable cardioverter defibrillator. Int Heart J 2009 0.75
64 Clinical impact of mapping strategies for treatment of ventricular tachycardias in patients with structural heart disease. Pacing Clin Electrophysiol 2015 0.75
65 Incessant monomorphic ventricular tachycardia induced by the proarrhythmic effect of amiodarone. Intern Med 2011 0.75
66 Assessment of ability of activation mapping by duodecapolar catheter to diagnose complete isthmus block utilizing electroanatomical mapping system. J Interv Card Electrophysiol 2006 0.75
67 Pilsicainide-induced verapamil sensitive idiopathic left ventricular tachycardia. Pacing Clin Electrophysiol 2006 0.75
68 Single-Coil Defibrillator Leads Yield Satisfactory Defibrillation Safety Margin in Hypertrophic Cardiomyopathy. Circ J 2016 0.75